𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dendritic cell-based immunotherapy of cancer from preclinical studies to clinical applications

✍ Scribed by Zitvogel; L. Triebel; F. Lotze; M.T. Escudier

Book ID
117665602
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
85 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

From pathogen to medicine: HIV-1-derived
From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy
✍ Melissa Dullaers; Kris Thielemans πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 272 KB

Over the years, the unique capacity of dendritic cells (DC) for efficient activation of naive T cells has led to their extensive use in cancer immunotherapy protocols. In order to be able to fulfil their role as antigen-presenting cells, the antigen of interest needs to be efficiently introduced and

Closed system generation of dendritic ce
Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy
✍ M. Elias; J. van Zanten; G.A.P. Hospers; A. Setroikromo; M.A. de Jong; L.F.M.H. πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 440 KB

Dendritic cells (DC) used for clinical trials should be processed on a large scale conforming to current good manufacturing practice (cGMP) guidelines. The aim of this study was to develop a protocol for clinical grade generation of immature DC in a closed-system. Aphereses were performed with the C